GBGB1702552.9A
GB201702552D0
(en)
|
2017-02-16 |
2017-02-16 |
Therapeutic agents for lysosomal storage disorders
|
EP18210763.1A
EP3482754B1
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
SI201730032T
SI3359146T1
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
CN201780062740.XA
CN109843275A
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical composition and purposes for lysosomal storage disease
|
EP24154769.4A
EP4342461A3
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
PL17767933T
PL3359146T3
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
MX2019001577A
MX2019001577A
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders.
|
MA45615A
MA45615B1
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and their uses against lysosomal overload diseases
|
PL18210763T
PL3482754T3
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
KR1020247021734A
KR20240110078A
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
MDE20181131T
MD3359146T2
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
AU2017308864A
AU2017308864B2
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
EP20215877.0A
EP3865126A1
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
ES18210763T
ES2849566T3
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical Compositions and Uses Aimed at Lysosomal Storage Disorders
|
PCT/IB2017/054928
WO2018029657A1
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
RU2021115932A
RU2021115932A
(en)
|
2016-08-11 |
2017-08-11 |
PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS AGAINST LYSOSOMAL DISEASES OF ACCUMULATION
|
RS20190334A
RS58478B1
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
SI201730613T
SI3482754T1
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
LTEP18210763.1T
LT3482754T
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
DK17767933.9T
DK3359146T3
(en)
|
2016-08-11 |
2017-08-11 |
PHARMACEUTICAL COMPOSITIONS AND USES AGAINST LYSOSOMAL STORAGE DISEASES
|
MA43876A
MA43876B1
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and their uses against lysosomal storage diseases
|
SG11201901048VA
SG11201901048VA
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
TNP/2019/000032A
TN2019000032A1
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
KR1020197007024A
KR102412724B1
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical Compositions and Uses Associated with Lysosomal Storage Diseases
|
MA055947A
MA55947A
(en)
|
2016-08-11 |
2017-08-11 |
PHARMACEUTICAL COMPOSITIONS AND USES DIRECTED TO LYSOSOMIAL STORAGE DISORDERS
|
KR1020227009897A
KR102467953B1
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
IL314107A
IL314107A
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
IL264610A
IL264610B1
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
HUE17767933A
HUE041914T2
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
CA3033557A
CA3033557A1
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
ES17767933T
ES2716133T3
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
PT17767933T
PT3359146T
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
KR1020227039341A
KR20220154849A
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
JP2019507811A
JP7393943B2
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses for lysosomal storage disorders
|
HUE18210763A
HUE052837T2
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
MEP-2019-60A
ME03340B
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
DK18210763.1T
DK3482754T3
(en)
|
2016-08-11 |
2017-08-11 |
PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS TARGETED FOR LYSOSOMAL STORAGE DISEASES
|
EP17767933.9A
EP3359146B1
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
BR112019002719-0A
BR112019002719A2
(en)
|
2016-08-11 |
2017-08-11 |
acetyl leucine, or a pharmaceutically acceptable salt thereof, for use in methods related to lysosomal deposition diseases
|
MDE20190593T
MD3482754T2
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
LTEP17767933.9T
LT3359146T
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
PT182107631T
PT3482754T
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
RS20210064A
RS61442B1
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
RU2019106493A
RU2749515C2
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and applications against lysosomal storage diseases
|
US16/324,301
US11400067B2
(en)
|
2016-08-11 |
2017-08-11 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
HK18112571.2A
HK1253282B
(en)
|
2016-08-11 |
2018-10-02 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
MX2021008432A
MX2021008432A
(en)
|
2016-08-11 |
2019-02-07 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders.
|
HRP20190344TT
HRP20190344T1
(en)
|
2016-08-11 |
2019-02-21 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
CY20191100279T
CY1121345T1
(en)
|
2016-08-11 |
2019-03-08 |
PHARMACEUTICAL COMPOSITIONS AND USES ADDRESSED TO LYSOSOMIC STORAGE DISORDERS
|
CY20211100017T
CY1123844T1
(en)
|
2016-08-11 |
2021-01-12 |
PHARMACEUTICAL COMPOSITIONS AND USES ADDRESSING LYSOSOMIC STORAGE DISORDERS
|
HRP20210153TT
HRP20210153T1
(en)
|
2016-08-11 |
2021-01-29 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
JP2022001694A
JP2022050564A
(en)
|
2016-08-11 |
2022-01-07 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
US17/854,027
US20220331278A1
(en)
|
2016-08-11 |
2022-06-30 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
AU2023202903A
AU2023202903A1
(en)
|
2016-08-11 |
2023-05-10 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
US18/430,858
US20240197663A1
(en)
|
2016-08-11 |
2024-02-02 |
Pharmaceutical compositions and uses directed to lysosomal storage disorders
|
JP2024027864A
JP2024059863A
(en)
|
2016-08-11 |
2024-02-27 |
Pharmaceutical composition for lysosomal storage disorder and use thereof
|